Other Disorders of the Eye without MCC: Inpatient Reimbursement Overview

DRG 125 groups inpatient stays for other disorders of the eye without Major Complication or Comorbidity, encompassing non-severe ocular diagnoses and procedures that do not qualify for higher-severity payment. It matters for inpatient reimbursement because correct DRG assignment determines the bundled Medicare payment and influences hospital case-mix and revenue.

Customize your policy alerts

Sign up for drg 125 policy alerts

Get alerted when payer policies referencing 125 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

DRG 125 Overview

DRG 125 covers inpatient cases for other disorders of the eye without Major Complication or Comorbidity. This group includes a range of non-severe ocular conditions and procedures that do not meet criteria for higher-severity classification. It matters for Medicare payment because it defines the bundled reimbursement for hospital stays where eye conditions are primary, influencing resource coding and payment level. Accurate assignment affects hospital Medicare revenue and case-mix reporting.

Clinical Trials

Acute procedural and perioperative safety studies investigating minimally invasive surgical techniques and anesthesia approaches for non-complex ocular conditions (for example, minor lid surgeries, non-penetrating glaucoma procedures, or retinal laser interventions). These studies enroll hospitalized patients who require short inpatient stays for eye procedures without major comorbid complications, and they collect intraoperative and immediate postoperative outcomes such as pain, bleeding, infection rates, and short-term visual function. Findings are relevant to providers and payers because they inform short-stay care pathways, resource use during the index admission, and risk stratification that can reduce length of stay and avoid escalation to higher-cost DRGs.
Comparative effectiveness trials evaluating different medical management strategies for acute but non-MCC eye disorders, such as randomized or pragmatic trials comparing topical regimens, anti-inflammatory protocols, or outpatient versus brief inpatient antibiotic strategies for infectious or inflammatory eye conditions. These trials focus on adults admitted for eye conditions that do not meet MCC criteria but require inpatient monitoring (e.g., severe conjunctivitis, uveitis flares, or corrosive injuries limited to ocular surfaces), assessing resolution time, readmission, adverse events, and functional vision outcomes. Results guide clinicians and payers on which conservative inpatient treatments provide the best balance of clinical benefit, safety, and cost, helping to define standardized inpatient care bundles and reduce unnecessary escalation of care.
Post-discharge outcomes and utilization studies that follow patients discharged under this DRG to measure 30- to 90-day functional vision recovery, outpatient follow-up adherence, rates of readmission or ED visits for ocular issues, and patient-reported vision-related quality of life. These observational cohorts or registry-based studies include diverse inpatient populations (older adults, patients with baseline ocular comorbidity) to identify predictors of poor recovery and gaps in care transitions such as missed ophthalmology follow-up or lack of rehabilitation services. This research is important for payers and hospitals to target transitional care interventions, allocate post-discharge resources, and reduce downstream utilization and costs associated with unresolved or recurring eye problems.

Related Codes

113-ORBITAL-PROCEDURES-WITH-CC-MCC

Orbital Procedures with CC/MCC: Inpatient Reimbursement Overview

114-ORBITAL-PROCEDURES-WITHOUT-CC-MCC

Orbital Procedures without CC/MCC: Inpatient Reimbursement Overview

115-EXTRAOCULAR-PROCEDURES-EXCEPT-ORBIT

Extraocular Procedures Except Orbit: Inpatient Reimbursement Overview

116-INTRAOCULAR-PROCEDURES-WITH-CC-MCC

Intraocular Procedures with CC/MCC: Inpatient Reimbursement Overview

117-INTRAOCULAR-PROCEDURES-WITHOUT-CC-MCC

Intraocular Procedures without CC/MCC: Inpatient Reimbursement Overview

121-ACUTE-MAJOR-EYE-INFECTIONS-WITH-CC-MCC

Acute Major Eye Infections with CC/MCC: Inpatient Reimbursement Overview

122-ACUTE-MAJOR-EYE-INFECTIONS-WITHOUT-CC-MCC

Acute Major Eye Infections without CC/MCC: Inpatient Reimbursement Overview

123-NEUROLOGICAL-EYE-DISORDERS

Neurological Eye Disorders: Inpatient Reimbursement Overview

124-OTHER-DISORDERS-OF-THE-EYE-WITH-MCC-OR-THROMBOLYTIC-AGENT

Other Disorders of the Eye with MCC or Thrombolytic Agent: Inpatient Reimbursement Overview

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Explore openpayer tools

View all tools

Clinical Trials

Acute procedural and perioperative safety studies investigating minimally invasive surgical techniques and anesthesia approaches for non-complex ocular conditions (for example, minor lid surgeries, non-penetrating glaucoma procedures, or retinal laser interventions). These studies enroll hospitalized patients who require short inpatient stays for eye procedures without major comorbid complications, and they collect intraoperative and immediate postoperative outcomes such as pain, bleeding, infection rates, and short-term visual function. Findings are relevant to providers and payers because they inform short-stay care pathways, resource use during the index admission, and risk stratification that can reduce length of stay and avoid escalation to higher-cost DRGs.
Comparative effectiveness trials evaluating different medical management strategies for acute but non-MCC eye disorders, such as randomized or pragmatic trials comparing topical regimens, anti-inflammatory protocols, or outpatient versus brief inpatient antibiotic strategies for infectious or inflammatory eye conditions. These trials focus on adults admitted for eye conditions that do not meet MCC criteria but require inpatient monitoring (e.g., severe conjunctivitis, uveitis flares, or corrosive injuries limited to ocular surfaces), assessing resolution time, readmission, adverse events, and functional vision outcomes. Results guide clinicians and payers on which conservative inpatient treatments provide the best balance of clinical benefit, safety, and cost, helping to define standardized inpatient care bundles and reduce unnecessary escalation of care.
Post-discharge outcomes and utilization studies that follow patients discharged under this DRG to measure 30- to 90-day functional vision recovery, outpatient follow-up adherence, rates of readmission or ED visits for ocular issues, and patient-reported vision-related quality of life. These observational cohorts or registry-based studies include diverse inpatient populations (older adults, patients with baseline ocular comorbidity) to identify predictors of poor recovery and gaps in care transitions such as missed ophthalmology follow-up or lack of rehabilitation services. This research is important for payers and hospitals to target transitional care interventions, allocate post-discharge resources, and reduce downstream utilization and costs associated with unresolved or recurring eye problems.

Related Codes

113-ORBITAL-PROCEDURES-WITH-CC-MCC

Orbital Procedures with CC/MCC: Inpatient Reimbursement Overview

114-ORBITAL-PROCEDURES-WITHOUT-CC-MCC

Orbital Procedures without CC/MCC: Inpatient Reimbursement Overview

115-EXTRAOCULAR-PROCEDURES-EXCEPT-ORBIT

Extraocular Procedures Except Orbit: Inpatient Reimbursement Overview

116-INTRAOCULAR-PROCEDURES-WITH-CC-MCC

Intraocular Procedures with CC/MCC: Inpatient Reimbursement Overview

117-INTRAOCULAR-PROCEDURES-WITHOUT-CC-MCC

Intraocular Procedures without CC/MCC: Inpatient Reimbursement Overview

121-ACUTE-MAJOR-EYE-INFECTIONS-WITH-CC-MCC

Acute Major Eye Infections with CC/MCC: Inpatient Reimbursement Overview

122-ACUTE-MAJOR-EYE-INFECTIONS-WITHOUT-CC-MCC

Acute Major Eye Infections without CC/MCC: Inpatient Reimbursement Overview

123-NEUROLOGICAL-EYE-DISORDERS

Neurological Eye Disorders: Inpatient Reimbursement Overview

124-OTHER-DISORDERS-OF-THE-EYE-WITH-MCC-OR-THROMBOLYTIC-AGENT

Other Disorders of the Eye with MCC or Thrombolytic Agent: Inpatient Reimbursement Overview

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.